Bristol Myers Squibb to Take Part in the UBS Virtual Global Healthcare Conference

05/12/2020

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020. Samit Hirawat, MD, EVP, Chief Medical Officer and Chris Boerner, EVP, Chief Commercialization Officer will answer questions at 11:40 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Media: media@bms.com 908-447-6134 Investor Relations: Tim Power, 609-252-7509, timothy.power@bms.com Nina Goworek, 908-673-9711, nina.goworek@bms.com

Multimedia Files:

Categories: Press Releases